E20 Hypoparathyroidism

Name of the Condition

• Hypoparathyroidism (ICD-10 Code: E20)

Summary

Hypoparathyroidism is a condition characterized by insufficient production of parathyroid hormone (PTH), leading to low calcium levels (hypocalcemia) and high phosphate levels (hyperphosphatemia). This imbalance can affect multiple body systems, including the nervous, muscular, and skeletal systems. The condition may be acute or chronic, with symptoms ranging from mild to severe depending on the degree of hormone deficiency.

Causes

The most common cause is damage to or removal of the parathyroid glands during neck surgery, such as thyroidectomy or parathyroidectomy. Other causes include autoimmune destruction of the glands, genetic disorders, or rare cases of infiltration by tumors or infections. In some instances, hypoparathyroidism may result from magnesium deficiency, which impairs PTH secretion or action.

Risk Factors

• Prior neck surgery involving the thyroid or parathyroid glands.
• Autoimmune conditions, such as autoimmune polyglandular syndrome.
• Genetic predisposition to parathyroid gland dysfunction.
• Magnesium deficiency or abnormal magnesium metabolism.
• Radiation therapy to the neck or head region.

Symptoms

• Muscle cramps, spasms, or twitching (tetany).
• Numbness or tingling in the fingers, toes, or around the mouth.
• Fatigue, weakness, or irritability.
• Seizures or abnormal heart rhythms (arrhythmias) in severe cases.
• Dry skin, brittle nails, or coarse hair.
• Anxiety or mood changes.

Diagnosis

Diagnosis is based on clinical symptoms and laboratory tests. Blood tests typically show low calcium, high phosphate, and low or undetectable PTH levels. Additional tests, such as magnesium levels or kidney function, may be performed to identify underlying causes. Electrocardiograms (ECGs) or nerve conduction studies may be used to assess cardiac or neurological involvement.

Treatment Options

Treatment focuses on restoring calcium and phosphate balance. Oral calcium supplements and active vitamin D analogs (e.g., calcitriol) are commonly used to raise calcium levels. Magnesium supplements may be necessary if deficiency is present. In severe or acute cases, intravenous calcium may be administered. Regular monitoring of calcium, phosphate, and kidney function is essential to adjust treatment and prevent complications.

Prognosis and Follow-Up

With proper treatment, most individuals can manage symptoms and maintain normal calcium levels. Chronic hypoparathyroidism requires lifelong monitoring to avoid complications like kidney stones, bone abnormalities, or cardiovascular issues. Follow-up appointments typically involve regular blood tests and adjustments to medication dosages. Prognosis is generally good when treatment is consistent and complications are addressed promptly.

Complications

• Severe hypocalcemia leading to seizures, arrhythmias, or respiratory distress.
• Kidney stones or nephrocalcinosis due to chronic calcium and phosphate imbalances.
• Cataracts or other eye problems.
• Bone density loss (osteopenia or osteoporosis) over time.
• Neurological complications, such as prolonged muscle spasms or cognitive changes.

Lifestyle & Prevention

• Ensure adequate calcium and vitamin D intake through diet or supplements as directed.
• Avoid excessive phosphate intake (e.g., from processed foods or sodas) to prevent imbalances.
• Stay hydrated and maintain a balanced diet to support overall metabolic health.
• Inform healthcare providers about the condition before any surgical procedures involving the neck.
• Monitor for symptoms and seek prompt care if they worsen.

When to Seek Professional Help

• Experiencing severe muscle spasms, seizures, or difficulty breathing.
• Noticeable changes in heart rate or rhythm.
• Persistent numbness, tingling, or weakness that affects daily activities.
• Symptoms of kidney stones (e.g., pain during urination or blood in urine).
• Unexplained fatigue, confusion, or mood changes that do not improve with treatment.

Tips for Medical Coders

When coding for hypoparathyroidism (E20), ensure documentation supports the diagnosis, including lab results (e.g., low calcium, low PTH) and clinical symptoms. Note any underlying causes, such as surgical history or autoimmune conditions, as these may influence coding specificity. Verify that the code aligns with the patient's current condition and treatment plan, and avoid using E20 for transient or post-surgical hypoparathyroidism unless it is documented as persistent.